5nda
From Proteopedia
(Difference between revisions)
Line 1: | Line 1: | ||
==NMR Structural Characterisation of Pharmaceutically Relevant Proteins Obtained Through a Novel Recombinant Production: The Case of The Pulmonary Surfactant Polypeptide C Analogue rSP-C33Leu.== | ==NMR Structural Characterisation of Pharmaceutically Relevant Proteins Obtained Through a Novel Recombinant Production: The Case of The Pulmonary Surfactant Polypeptide C Analogue rSP-C33Leu.== | ||
- | <StructureSection load='5nda' size='340' side='right'caption='[[5nda | + | <StructureSection load='5nda' size='340' side='right'caption='[[5nda]]' scene=''> |
== Structural highlights == | == Structural highlights == | ||
- | <table><tr><td colspan='2'>[[5nda]] is a 1 chain structure with sequence from [ | + | <table><tr><td colspan='2'>[[5nda]] is a 1 chain structure with sequence from [https://en.wikipedia.org/wiki/Sus_scrofa Sus scrofa]. Full experimental information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5NDA OCA]. For a <b>guided tour on the structure components</b> use [https://proteopedia.org/fgij/fg.htm?mol=5NDA FirstGlance]. <br> |
- | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[ | + | </td></tr><tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[https://proteopedia.org/fgij/fg.htm?mol=5nda FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5nda OCA], [https://pdbe.org/5nda PDBe], [https://www.rcsb.org/pdb/explore.do?structureId=5nda RCSB], [https://www.ebi.ac.uk/pdbsum/5nda PDBsum], [https://prosat.h-its.org/prosat/prosatexe?pdbcode=5nda ProSAT]</span></td></tr> |
</table> | </table> | ||
+ | == Function == | ||
+ | [https://www.uniprot.org/uniprot/PSPC_PIG PSPC_PIG] Pulmonary surfactant associated proteins promote alveolar stability by lowering the surface tension at the air-liquid interface in the peripheral air spaces. | ||
<div style="background-color:#fffaf0;"> | <div style="background-color:#fffaf0;"> | ||
== Publication Abstract from PubMed == | == Publication Abstract from PubMed == | ||
Line 20: | Line 22: | ||
</StructureSection> | </StructureSection> | ||
[[Category: Large Structures]] | [[Category: Large Structures]] | ||
- | [[Category: | + | [[Category: Sus scrofa]] |
- | [[Category: Johansson | + | [[Category: Johansson J]] |
- | [[Category: Kronqvist | + | [[Category: Kronqvist N]] |
- | [[Category: Nordling | + | [[Category: Nordling K]] |
- | [[Category: Pioselli | + | [[Category: Pioselli B]] |
- | [[Category: Rising | + | [[Category: Rising A]] |
- | [[Category: Venturi | + | [[Category: Venturi L]] |
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + | ||
- | + |
Revision as of 10:21, 14 June 2023
NMR Structural Characterisation of Pharmaceutically Relevant Proteins Obtained Through a Novel Recombinant Production: The Case of The Pulmonary Surfactant Polypeptide C Analogue rSP-C33Leu.
|